CRESPONSE

Serial Number 90176844
606

Registration Progress

Application Filed
Sep 13, 2020
Under Examination
May 18, 2021
Approved for Publication
Mar 23, 2021
Published for Opposition
Mar 23, 2021
Registered

Trademark Image

CRESPONSE

Basic Information

Serial Number
90176844
Filing Date
September 13, 2020
Published for Opposition
March 23, 2021
Abandonment Date
June 24, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 24, 2024
Classes
044

Rights Holder

Curesponse Ltd.

99
Address
6 Weitzman Street
Tel Aviv Medical Center (TAMC)
Tel Aviv 6423906
IL

Ownership History

Curesponse Ltd.

Original Applicant
99
Tel Aviv IL

Curesponse Ltd.

Owner at Publication
99
Tel Aviv IL

Legal Representation

Attorney
Abigail Rubinstein

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description Documents
Jul 12, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 24, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 30, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 29, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 29, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 17, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 17, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 20, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 18, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 18, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 17, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 17, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 17, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 20, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 18, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 18, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
May 18, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 14, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 14, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 14, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
May 18, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 23, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 23, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 3, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 12, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 12, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 12, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 12, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 12, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 8, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 7, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 7, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 25, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 25, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 25, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 21, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 21, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 16, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Medical testing for diagnostic or treatment purposes; Providing medical testing services in the field of diagnosis and treatment of cancer diseases; medical testing services for diagnostic or treatment purposes in the field of optimization of pharmaceutical treatment for cancer patients; provision of medical information in the field of cancer screening, diagnosis and treatment; health care services for treating cancer

Additional Information

Pseudo Mark
C RESPONSE; SEE RESPONSE; CURE RESPONSE

Classification

International Classes
044